HLA-DR allele polymorphism and multiple sclerosis in Chinese populations: a meta-analysis

Mult Scler. 2011 Apr;17(4):382-8. doi: 10.1177/1352458510391345. Epub 2010 Dec 21.

Abstract

Background: The association of human leukocyte antigen (HLA) genes and multiple sclerosis (MS) has been extensively investigated in Caucasians, but less so in Oriental races such as Chinese.

Objectives: To review studies on association of HLA class II alleles with MS in the Chinese population.

Methods: An extensive search for published studies up to June 2010 was performed in the electronic databases. The meta-analysis facilities in the NCSS statistical package were utilized to analyze the findings in these studies. The odds ratios (ORs) of HLA-DR allele distributions in MS were analyzed against controls.

Results: Eleven case-control studies were identified: nine genotyping and two serotyping studies. Six genotyping studies were suitable for HLA-DRB1 allele meta-analysis, which showed that HLA-DRB1*15 was associated with risk of MS in the combined group (308 cases and 407 controls; OR 1.39) while the HLA-DRB1*09 and HLA-DRB1*0901 alleles were protective. When the equivalent serotypes in these six studies were combined with the results from the two serotyping studies (431 cases and 652 controls) for a meta-analysis of HLA-DR serotypes, HLA-DR2 was a risk factor (OR 1.63) and HLA-DR9 was strongly protective in the combined group (OR 0.64).

Conclusions: Although limited data are available, our meta-analysis suggests that HLA-DR2/DRB1*15 are also associated with risk of MS in the Chinese population but less strongly so than in Western MS populations, whereas HLA-DR9 alleles appear to confer resistance in this population.

Publication types

  • Meta-Analysis

MeSH terms

  • Alleles
  • Asian People / genetics*
  • Case-Control Studies
  • China
  • Genetic Predisposition to Disease
  • Genotype
  • HLA-DR Antigens / genetics*
  • Humans
  • Multiple Sclerosis / ethnology
  • Multiple Sclerosis / genetics*
  • Polymorphism, Genetic*

Substances

  • HLA-DR Antigens